N
NEUP
Neuphoria Therapeutics Inc
4.660
-0.010-0.21%After Hours: 4.800 +0.140 +3.00%16:07 06/09 EDT
OPEN/PREV CLOSE4.640/4.670
TODAY RANGE4.522-4.890
VOL52.70K
MARKET CAP25.19M
52 WEEK RANGE3.645-21.40
AVG VOL (3M)51.02K
% TURNOVER0.98%
TURNOVER--
P/E (TTM)-0.5317
% RANGE7.88%
EPS(TTM)-8.7651
P/E(FORWARD)-1.1450
P/B0.8516
BVPS5.47
DIVIDEND--
P/S0.5891
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP23.25M
SHARES OUTSTANDING5.40M
NEXT EARNINGS09/28-10/02
FREE FLOAT4.99M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/26 21:42
Neuphoria Receives Milestone Revenue From Pfizer KAT6 Trial
Benzinga·05/15 18:44
Deal Dispatch: GoPro Retains Houlihan Lokey In Strategic Review, Brookfield Buys World Freight Company, YesCare Corp. Bankruptcy
TipRanks·05/15 18:23
Neuphoria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Dow Jones·05/15 17:43
Neuphoria Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
Benzinga·05/15 17:34
HC Wainwright & Co. Downgrades Neuphoria Therapeutics to Neutral
Benzinga·05/15 13:23
Neuphoria Therapeutics Q3 EPS $(0.09) Beats $(0.97) Estimate
TipRanks·01/08 11:32
Neuphoria Therapeutics Announces CEO Transition and Consulting Role
TipRanks·12/17/2025 21:39
Neuphoria Therapeutics Shareholders Align on Key Proposals
TipRanks·12/08/2025 13:05
Neuphoria announces ISS recommends shareholders vote ‘FOR’ director nominees
Dow Jones·12/05/2025 13:05
Neuphoria Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·12/05/2025 13:05
Neuphoria Therapeutics Price Target Cut to $7.00/Share From $21.00 by HC Wainwright & Co.
Benzinga·12/05/2025 12:55
HC Wainwright & Co. Maintains Buy on Neuphoria Therapeutics, Lowers Price Target to $7
Same Industry
Name/Symbol
Change%
Price